Introduction
Advances in surgical expertise, technical equipment as well as anesthetic and neonatal intensive care management, have contributed to decreased mortality and morbidity rates of patient with esophageal atresia (EA) in the last decades.
Another milestone in EA surgery was achieved with the introduction of minimal invasive surgery. In 1999, the first successful thoracoscopic repair of a pure EA was performed.
9
One year later, Rothenberg reported the first thoracoscopic fistula ligation and primary anastomosis.
10 Since then, minimal invasive EA repair is deployed in increasing numbers worldwide.
11
This report aims to elucidate and compare the outcome development of EA throughout the decades since the first end-to-end anastomosis to modern era. Besides mortality rates, we focused on common and severe postoperative complications after EA repair, such as occurrence of recurrent fistula, anastomotic leakage, and stricture.
Materials and Methods
In January 2018, a PubMed literature search was conducted for the years 1944 to 2017 using different combinations of the following keywords: "esophageal/oesophageal atresia," "outcome," "experience," "management," and "follow-up/ follow up." Additionally, reference lists of included papers were screened manually for further studies. Duplicates were deleted.
Selection Criteria and Data Extraction
Relevant articles were reviewed by title, abstract, and keywords, and full-text of selected articles were assessed by one of the authors (J.Z.). Only articles in English language were considered. Reports on long-gap EA only, case reports, and reviews without original patient data were excluded. We focused on mortality and rates of recurrent fistula, leakage, and stricture. The data were standardized extracted into an electronic database, containing the characteristics of the study (authors, publication year, time frame of the study, number of patients, age/mean follow-up time, mortality rate, and percentage of patients with recurrent fistula, leakage, and stricture).
Statistical Analysis
Microsoft Excel was used for data analysis. The percentage of patients with recurrent fistula, leakage, and stricture as well as the percentage of patients who died was compared between the different decades.
Results
A total of 747 articles were identified through literature search, of which 118 manuscripts met the inclusion criteria (►Fig. 1). Included articles and their reported outcomes are shown in ►Table 1. An overview of the included study types is given in ►Table 2. All except for seven were retrospective studies.
3,12-17 One was a randomized controlled trial as reported by Upadhyaya et al. 18 It is notable that some reports comprise outcome data of several decades, which were matched to the related period. A total of 102 (86%) of the included studies reported on mortality. Reported mortality rate after EA repair decreased markedly over time. It dropped from 100% in the presurgical era to 81% in the 1940s and to 54% in the 1950s. Further reduction followed in the next decades with 36% in 1960 to 1969, 28% in 1970 to 1979, and 16% in 1980 to 1989 and 1990 to 1999. In the postmillennial era, mortality rate after EA repair decreased further to 12% in 2000 to 2009, and in the current decade, it is 9% (►Fig. 2).
Reported rates of recurrent fistula varied over time between 4 and 9%, and leakage rate varied between 11 and 16% (►Fig. 2). The number of studies reporting on recurrent fistula and leakage rate were 67 (56%) and 89 (75%), respectively, in this study.
Ninety-one (77%) out of 118 included papers reported on stricture rate. Stricture rate showed a substantial increase in the last decade. Between 1940 and 2009, the reported rate varied between 25 and 31%, whereas the average stricture rate was 38% in 2010 to 2017 (►Fig. 2). Furthermore, use and duration of paralysis, mechanical ventilation, antibiotic treatment, as well as antacid therapy vary widely among different centers worldwide.
Discussion

11
Even high-risk groups (very-low-birth-weight infants/ extremely premature babies) present currently with acceptable survival rates. Hannon et al demonstrated 50% survival in EA patients with a birth weight below 1 kg. 27 However, in Table 2 Overview of included study types (multiple selections possible)
Study type Number of studies
Randomized controlled trials 1
Prospective studies 7
Retrospective studies 110
Multicenter studies 10
Single-center studies 100
Comparative Studies 7 Fig. 2 Reported mortality rate decreased from 100% before 1941 to 54% in 1950 to 1959, 28% in 1970 to 1979, 16% in 1990 to 1999, and 9% nowadays. Rates of recurrent fistula varied over time between 4 and 9% and leakage rate varied between 11 and 16%. However, stricture rate increased from 25 to 38%.
their study, all infants below 800 g body weight had poor outcome. 27 In contrast, there is 95% expected survival in babies of more than 1500 g body weight, depending on their comorbidites.
27,28
Although several authors published a survival rate of 100% in their center, [22] [23] [24] 26, 29, 30 the overall mortality found in this study was between 9 and 11% in the last two decades. This is due to the fact that we also included studies with very-lowbirth-weight infants and articles from third world countries in this report. 27, [31] [32] [33] [34] However, it has been suggested that birth weight is nowadays not an important factor as it was previously, although major cardiac anomalies are still of poor prognostic aspect. reported on their experiences, whereas the majority presented single center data. Likewise, also comparative studies were rare. 22, 23, 29, [49] [50] [51] [52] Therefore, the current level of evidence in EA treatment is very low, and reference networks such as The European Reference Network on Rare inherited and congenital anomalies (ERNICA), which aims to assure quality treatment with high levels of evidence for EA in the future, are urgently needed.
The authors are aware of study limitations. A key point is the heterogeneity of included EA cases. No distinction was made between different types of EA (gap length, existence of a tracheoesophageal fistula). As we aimed to show the worldwide overall outcome of morbidity and mortality over time course, the articles were not extracted for surgical technique (open vs. minimal invasive, anastomotic technique, and primary vs. staged repair), birth weight/age, associated anomalies, time of follow-up, or country of origin (industrial states vs. third world countries). There is also a potential bias in study selection for the current manuscript. Amount of accessibility of papers from the early decades was restricted. Furthermore, there is a considerable variety of therapeutic regimen and treatment strategies among the different centers involved in EA treatment as well as the possibility of selection bias in the included studies themselves.
Conclusion
This article reflects the heterogeneity of EA, its patients, and its repair modalities during the course of 80 years. The worldwide mortality rate decreased from 100% in the presurgical era to a single-digit range in the last decade. Along with the decrease in mortality, there is a shift to the importance of major postoperative complications and long-term morbidity regardless of surgical technique. Therefore, close and regular follow-up of EA patients must be mandatory to assure health and normal development not only during childhood, but also for transition into adult care. Further studies, particularly prospective or randomized controlled trials, or at least consensus conferences, are needed to achieve higher levels of evidence and quality improvement for current therapeutic strategies for EA treatment.
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